Many view the scalable, affordable manufacturing of stem cell-derived therapies as one of regenerative medicine’s greatest bottlenecks.

Cellular manufacturing systems (CMS) represent a pivotal approach to modern industrial production, in which machines and workstations are organised into discrete cells dedicated to the manufacture of ...

A reconfigurable manufacturing system (RMS), one of state-of-the-art manufacturing system technologies, is the one designed at the outset for rapid changes in its hardware and software components in ...

Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...

WATERTOWN, Mass.--(BUSINESS WIRE)--SQZ Biotechnologies (NYSE: SQZ) announced today that the company’s first generation, integrated point-of-care (POC) cell therapy manufacturing system demonstrated ...

Detroit Manufacturing Systems (DMS) and InductEV have announced a new agreement to streamline wireless commercial vehicle charging operations, manufacturing, quality by design, and supply chain to ...

Cellular Origins, a TTP company, acquired the ACTIA (Autologous Cell Therapy Industrial Automation) Platform IP, developed by Geoff Hodge while CEO of SOTIO Biotech US. The ACTIA Platform complements ...

Survey results specific to private cellular deployments show that although manufacturing firms in Germany and Malaysia have seen consistent, linear maturation in private cellular growth since 2024, ...

Mytos' automated CDMO provides a rapid and consistent path to scale. The iDEM™ technology lowers the cost per dose, ...